SCHEMBL8902307

SCHEMBL8902307

CC(C)CCC[C@@H](C)[C@H]1CCC2C3CCC4CC(OS(=O)(=O)[O-])CC[C@]4(C)C3CC[C@@]21C.[Na+]

nearest known ligand 0.82

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
FGF1 known ✓ P05230 9/20 0.69
ST6GAL1 P15907 1/20 0.82
HPSE Q9Y251 12/20 0.69
CDC25A P30304 2/20 0.69
POLA1 P09884 1/20 0.69
FGF2 P09038 8/20 0.67
CYP2D6 P10635 1/20 0.65
CYP2C19 P33261 1/20 0.65
INPP5D Q92835 1/20 0.64
ABCC4 O15439 1/20 0.64
VDR P11473 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8902302 1.00 ST6GAL1 (0.82) ST6GAL1HPSEFGF1CDC25APOLA1
SCHEMBL13347854 0.91 VDR (0.76) ST6GAL1HPSEFGF1CDC25APOLA1
SCHEMBL17124639 0.91 VDR (0.76) ST6GAL1HPSEFGF1CDC25APOLA1
SCHEMBL13311422 0.91 VDR (0.76) ST6GAL1HPSEFGF1CDC25APOLA1
SCHEMBL25063600 0.90 ABCC4 (0.78) ST6GAL1HPSECDC25APOLA1CYP2D6
SCHEMBL8903512 0.90 ABCC4 (0.78) ST6GAL1HPSECDC25APOLA1CYP2D6
SCHEMBL8902867 0.90 ABCC4 (0.78) ST6GAL1HPSECDC25APOLA1CYP2D6
SCHEMBL23594716 0.90 ABCC4 (0.78) ST6GAL1HPSECDC25APOLA1CYP2D6
Ammonia Solution, Strong SCHEMBL30074798 0.89 ABCC4 (0.76) ST6GAL1HPSECDC25APOLA1CYP2D6
SCHEMBL18195977 0.87 CDC25A (0.65) ST6GAL1HPSEFGF1CDC25APOLA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5610180-A TOCOPHEROL AND CHOLESTEROL DERIVATIVES, CYTOPROTECTIVE AGENTS VIRGINIA COMMONWEALTH UNIVERSITY (US) 1997-03-11 US disclosed
US-5336485-A Administering cholestane phthalates, succinates or sulfates before administering tacrine CENTER FOR INNOVATIVE TECHNOLOGY (US) 1994-08-09 US disclosed
US-5198432-A Cytoprotective agents CENTER FOR INNOVATIVE TECHNOLOGY (US) 1993-03-30 US disclosed